Tech Company Financing Transactions
Montara Therapeutics Funding Round
On 7/30/2024, Montara Therapeutics received $8 million in Seed investment from SV Health Investors, Two Bear Capital and Dolby Family Ventures.
Transaction Overview
Company Name
Announced On
7/30/2024
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Seed
Investors
SV Health Investors (Lead Investor) (Dirk Landgraf)
Two Bear Capital (Lead Investor) (Seth Strattan)
Proceeds Purpose
The company intends to use the funds to advance its universal peripheral blocker and a neurological disease-targeting drug with proven clinical benefit but severe dose-limiting peripheral side effects. Montara has also initiated chemistry on subsequent programs for Alzheimer's and Parkinson's disease.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
135 Mississippi St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Montara, we're developing safer, more efficacious therapies to improve the lives of patients with neurological diseases. Our mission is to develop innovative therapies for diseases of the brain by leveraging our proprietary platform to enhance drug safety and efficacy and enable the drugging of targets previously considered undruggable.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicholas Hertz
Vice President
Randall Chin
Vice President
Zachary Hill
Vice President
Rishi Rakhit
VP - Operations
Max Lebovitz
Browse more venture capital transactions:
Prev: 7/30/2024: Monto venture capital transaction
Next: 7/30/2024: Hyperbolic venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs